75 results
6-K
EX-99.7
QGEN
Qiagen NV
31 Oct 23
Notice of the Annual General Meeting of Shareholders
6:58pm
a new member with the appointment of Dr. Rick Bright, an American immunologist, an expert in vaccine, drugs and diagnostic development, and a former … .
The Board has designated Dr. Haag as an “Audit Committee Financial Expert” as that term is defined in the U.S. Securities and Exchange Commission rules
6-K
EX-99.2
QGEN
Qiagen NV
31 Oct 23
Notice of the Annual General Meeting of Shareholders
6:58pm
Stock Exchange Listed Company Manual.
The Board has designated Dr. Haag as an “Audit Committee Financial Expert” as that term is defined in the U.S
6-K
QGEN
Qiagen NV
8 Nov 22
Current report (foreign)
6:49pm
. Haag as an “Audit Committee Financial Expert” as that term is defined in the U.S. Securities and Exchange Commission rules adopted pursuant … - designed for use for the detection of TB in low-resource, high-burden countries (Approved by the Global Fund's Expert Review Panel Diagnostics (ERPD
6-K
spfd1p 3e
9 Feb 22
Current report (foreign)
4:39pm
6-K
7zqd639
2 Aug 21
Current report (foreign)
12:00am
6-K
um2sms0twjp
5 Aug 20
Current report (foreign)
12:00am
SC TO-T/A
1tv41l
15 Jun 20
Third party tender offer statement (amended)
5:12pm
SC 14D9/A
d7k56exed57
15 Jun 20
Tender offer solicitation (amended)
4:09pm
SC 14D9
EX-99
6tz8x3k
18 May 20
Tender offer solicitation
6:22am
SC 14D9
EX-99
wbef4pkiy8xv9
18 May 20
Tender offer solicitation
6:22am
SC 14D9
EX-99
s32lg v2nr4c24hyqajp
18 May 20
Tender offer solicitation
6:22am
SC 14D9
EX-99
0j19tr 8r4y
18 May 20
Tender offer solicitation
6:22am
SC TO-T/A
EX-99
3u60 nskwjt
18 May 20
Third party tender offer statement (amended)
6:02am
SC TO-T/A
EX-99
ae3s qljhmycz2idjyex
18 May 20
Third party tender offer statement (amended)
6:02am